A Study to Evaluate a Resiliency Program for Healthcare Professionals During a Pandemic

Overview

About this study

The purpose of this study is to evaluate the feasibility of a resiliency program to provide an effective and sustainable solution to several important problems experienced by medical professionals.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

 

Inclusion Criteria:

  • 18 years of age or older at the time of consent.
  • Frontline healthcare professional.
  • Have access to an Apple or Android device.
  • Not pregnant by subject self-report at time of consent.
  • Have the ability to provide informed consent.
  • Have no contraindicating comorbid health condition as determined by the clinical investigators.

Exclusion Criteria: 

  • Currently (within the past 3 weeks) been practicing mindfulness training on a weekly/regular basis.
  • Currently (within the past 3 weeks) been undergoing an additional program (e.g., CAM) to improve quality of life or sleep.
  • Currently (within 3 weeks) been enrolled in another clinical or research program (e.g., CAM) which intervenes on the patients’ QOL, stress or sleep.
  • An unstable medical or mental health condition as determined by the physician investigator.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Ivana Croghan, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions